Exaggerated 17-hydroxyprogesterone response to intravenous infusions of recombinant human LH in women with polycystic ovary syndrome (Q30432819)

21 June 2017

Exaggerated 17-hydroxyprogesterone response to intravenous infusions of recombinant human LH in women with polycystic ovary syndrome (English)

1 reference

polycystic ovary syndrome

21 June 2017

1 reference

1 reference

7

1 reference

21 June 2017

Christopher R McCartney

1

1 reference

21 June 2017

Amy B Bellows

2

1 reference

21 June 2017

Melissa B Gingrich

3

1 reference

21 June 2017

Yun Hu

4

1 reference

21 June 2017

William S Evans

5

1 reference

21 June 2017

John C Marshall

6

1 reference

21 June 2017

21 January 2004

1 reference

American Journal of Physiology - Endocrinology and Metabolism

21 June 2017

1 reference

21 June 2017

286

1 reference

21 June 2017

6

1 reference

21 June 2017

E902-8

1 reference

Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome

21 June 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00415.2003

Is there a physiological role for gonadotrophin oligosaccharide heterogeneity in humans? III. Luteinizing hormone heterogeneity: a medical physiologist's perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00415.2003

Ovarian hyperandrogenism in adult female rhesus monkeys exposed to prenatal androgen excess

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00415.2003

Neuroendocrine regulation of the corpus luteum in the human. Evidence for pulsatile progesterone secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00415.2003

Augmented frequency and mass of LH discharged per burst are accompanied by marked disorderliness of LH secretion in adolescents with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00415.2003

Ovarian steroidogenic response to human chorionic gonadotrophin in obese women with polycystic ovary syndrome: effect of metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00415.2003

Metformin treatment reduces ovarian cytochrome P-450c17alpha response to human chorionic gonadotrophin in women with insulin resistance-related polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00415.2003

Neuroendocrine aspects of polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00415.2003

Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00415.2003

Embryo implantation and GnRH antagonists: ovarian actions of GnRH antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00415.2003

Role of cytochrome P450c17 in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00415.2003

The effects of metformin on insulin resistance and ovarian steroidogenesis in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00415.2003

The effects of long-term metformin treatment on adrenal and ovarian steroidogenesis in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00415.2003

Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease: indirect evidence for partial gonadotroph desensitization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00415.2003

Gonadotrophin and gonadal steroid response to a single dose of a long-acting agonist of gonadotrophin-releasing hormone in ovulatory and anovulatory women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00415.2003

10.1152/AJPENDO.00415.2003

21 January 2018

Identifiers

DOI

1 reference

21 June 2017

1 reference